-
2701por Matos, Guilherme Inocêncio, Covas, Claudia de J Fernandes, Bittar, Rita de Cássia, Gomes-Silva, Adriano, Marques, Fabiana, Maniero, Viviane C, Amato, Valdir S, Oliveira-Neto, Manoel P, Mattos, Marise da Silva, Pirmez, Claude, Sampaio, Elizabeth P, Moraes, Milton O, Da-Cruz, Alda Maria“…METHODS: Brazilian ATL patients (78 cutaneous, CL, and 58 mucosal leishmaniasis, ML) and 609 healthy volunteers were evaluated. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2702por Lecoeur, Hervé, Buffet, Pierre, Morizot, Gloria, Goyard, Sophie, Guigon, Ghislaine, Milon, Geneviève, Lang, Thierry“…BACKGROUND: Because topical therapy is easy and usually painless, it is an attractive first-line option for the treatment of localized cutaneous leishmaniasis (LCL). Promising ointments are in the final stages of development. …”
Publicado 2007
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2703
-
2704por Collin, Nicolas, Gomes, Regis, Teixeira, Clarissa, Cheng, Lily, Laughinghouse, Andre, Ward, Jerrold M., Elnaiem, Dia-Eldin, Fischer, Laurent, Valenzuela, Jesus G., Kamhawi, Shaden“…Immunity to a sand fly salivary protein protects against visceral leishmaniasis (VL) in hamsters. This protection was associated with the development of cellular immunity in the form of a delayed-type hypersensitivity response and the presence of IFN-γ at the site of sand fly bites. …”
Publicado 2009
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2705“…More recently, post kala-azar dermal leishmaniasis (PKDL) cases have followed kala-azar peaks. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2706por Clements, Meredith F., Gidwani, Kamlesh, Kumar, Rajiv, Hostomska, Jitka, Dinesh, Diwakar S., Kumar, Vijay, Das, Pradeep, Müller, Ingrid, Hamilton, Gordon, Volfova, Vera, Boelaert, Marleen, Das, Murari, Rijal, Suman, Picado, Albert, Volf, Petr, Sundar, Shyam, Davies, Clive R., Rogers, Matthew E.“…Antibody (IgG) responses to the saliva of Phlebotomus argentipes were investigated using serum samples from regions of India endemic and non-endemic for visceral leishmaniasis (VL). By pre-adsorbing the sera against the saliva of the competing human-biting but non-VL vector P. papatasi, we significantly improved the specificity of a P. argentipes saliva enzyme-linked immunosorbent assay. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2707por Hernández-Ruiz, Joselín, Salaiza-Suazo, Norma, Carrada, Georgina, Escoto, Sofía, Ruiz-Remigio, Adriana, Rosenstein, Yvonne, Zentella, Alejandro, Becker, Ingeborg“…Leishmania mexicana (Lm) causes localized (LCL) and diffuse (DCL) cutaneous leishmaniasis. DCL patients have a poor cellular immune response leading to chronicity. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2708por Osorio, Yaneth, Travi, Bruno L., Renslo, Adam R., Peniche, Alex G., Melby, Peter C.“…BACKGROUND: New drugs are needed to treat visceral leishmaniasis (VL) because the current therapies are toxic, expensive, and parasite resistance may weaken drug efficacy. …”
Publicado 2011
Enlace del recurso
Enlace del recurso
Enlace del recurso
Texto -
2709“…We earlier showed that 18β-glycyrrhetinic acid (GRA), a pentacyclic triterpenoid from licorice root, could completely cure visceral leishmaniasis in BALB/c mouse model. This was associated with induction of nitric oxide and proinflammatory cytokine production through the up regulation of NF-κB. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2710por Sorkhroodi, F Zamani, Naeini, AM Alavi, Ramazani, AR Zahraei, Ghazvini, MR Aghaye, Mohebali, M, Keshavarz, SA“…BACKGROUND: Successful therapy of leishmaniasis depends on effective cellular immune response. …”
Publicado 2010
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2711por Marco, Jorge D, Barroso, Paola A, Mimori, Tatsuyuki, Locatelli, Fabricio M, Tomatani, Ayako, Mora, María C, Cajal, S Pamela, Nasser, Julio R, Parada, Luis A, Taniguchi, Taketoshi, Korenaga, Masataka, Basombrío, Miguel A, Hashiguchi, Yoshihisa“…Here we evaluated the performance of this method in the diagnosis of American tegumentary leishmaniasis (ATL) and the rapid identification of Leishmania spp. directly from clinical specimens. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2712
-
2713por dos Santos Marques, Letícia Helena, Gomes, Luciana Inácia, da Rocha, Iara Caixeta Marques, da Silva, Thaís Almeida Marques, Oliveira, Edward, Morais, Maria Helena Franco, Rabello, Ana, Carneiro, Mariângela“…BACKGROUND: An important issue associated with the control of visceral leishmaniasis is the need to identify and understand the relevance of asymptomatic infection caused by Leishmania infantum. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2714por Carneiro, Marcia W., Santos, Diego M., Fukutani, Kiyoshi F., Clarencio, Jorge, Miranda, Jose Carlos, Brodskyn, Claudia, Barral, Aldina, Barral-Netto, Manoel, Soto, Manuel, de Oliveira, Camila I.Enlace del recurso
Publicado 2012
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2715por Khan, Md Gulam Musawwir, Bhaskar, Khondaker Rifat Hasan, Salam, Md Abdus, Akther, Tania, Pluschke, Gerd, Mondal, Dinesh“…BACKGROUND: Visceral leishmaniasis (VL) remains as one of the most neglected tropical diseases with over 60% of the world’s total VL cases occurring in the Indian subcontinent. …”
Publicado 2012
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2716por Martins, Vivian T., Chávez-Fumagalli, Miguel A., Costa, Lourena E., Canavaci, Adriana M. C., Lage, Paula S., Lage, Daniela P., Duarte, Mariana C., Valadares, Diogo G., Magalhães, Rubens D. M., Ribeiro, Tatiana G., Nagem, Ronaldo A. P., DaRocha, Wanderson D., Régis, Wiliam C. B., Soto, Manuel, Coelho, Eduardo A. F., Fernandes, Ana Paula, Tavares, Carlos A. P.Enlace del recurso
Publicado 2013
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2717por van den Bogaart, Erika, Berkhout, Marieke MZ, Nour, Ayman BYM, Mens, Pètra F, Talha, Al-Badawi A, Adams, Emily R, Ahmed, Hashim BM, Abdelrahman, Samira H, Ritmeijer, Koert, Nour, Bakri YM, Schallig, Henk DFH“…BACKGROUND: In areas where visceral leishmaniasis (VL) and malaria are co-endemic, co-infections are common. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2718por Matlashewski, Greg, Das, Vidya Nand Ravi, Pandey, Krishna, Singh, Dharmendra, Das, Sushmita, Ghosh, Ayan Kumar, Pandey, Ravindra Nath, Das, Pradeep“…BACKGROUND: Antibody-detecting rapid diagnostic tests (RDTs) against rK39 are available to aid in the diagnosis of visceral leishmaniasis (VL). Although these rK39 RDTs have been developed, validated and approved for use with serum, they are universally performed using whole blood. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2719por Cenderello, Giovanni, Pasa, Ambra, Dusi, Andrea, Dentone, Chiara, Toscanini, Federica, Bobbio, Nicoletta, Bondi, Elisabetta, Del Bono, Valerio, Izzo, Manuela, Riccio, Giovanni, Anselmo, Marco, Giacchino, Raffaella, Marazzi, Maria Grazia, Pagano, Gabriella, Cassola, Giovanni, Viscoli, Claudio, Ferrea, Giuseppe, De Maria, Andrea“…BACKGROUND: Visceral Leishmaniasis (VL) is endemic in 88 countries, in areas of relatively low incidence with a relevant proportion of immune suppressed patients clinical presentation, diagnosis and management may present difficulties and pitfalls. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
2720por Abass, Elfadil, Bollig, Nadine, Reinhard, Katharina, Camara, Bärbel, Mansour, Durria, Visekruna, Alexander, Lohoff, Michael, Steinhoff, Ulrich“…BACKGROUND: For effective control of visceral leishmaniasis (VL) in East Africa, new rapid diagnostic tests are required to replace current tests with low sensitivity. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto